Works matching Liver diseases
Results: 5000
睡眠障碍与非酒精性脂肪性肝病.
- Published in:
- Journal of Nanjing Medical University: Natural Sciences, 2023, v. 43, n. 7, p. 1022, doi. 10.7655/NYDXBNS20230718
- By:
- Publication type:
- Article
Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease.
- Published in:
- Frontiers in Physiology, 2021, v. 12, p. 1, doi. 10.3389/fphys.2021.707429
- By:
- Publication type:
- Article
Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease.
- Published in:
- Journal of Personalized Medicine, 2023, v. 13, n. 5, p. 830, doi. 10.3390/jpm13050830
- By:
- Publication type:
- Article
Clinical and Metabolic Characteristics of Non-Alcoholic Fatty Liver Disease Patients in Saudi Arabia: Data from the Systematic Observatory Liver Disease (SOLID) Registry.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2021, v. 14, p. 1167, doi. 10.2147/DMSO.S300051
- By:
- Publication type:
- Article
Metabolic Associated Fatty Liver Disease as the New Nomenclature for Nonalcoholic Fatty Liver Disease.
- Published in:
- Medical Journal of Viral Hepatitis, 2022, v. 6, n. 2, p. 4, doi. 10.21608/mjvh.2022.234476
- By:
- Publication type:
- Article
The Portal Venous Pulsatility Index and Main Portal Vein Diameter as Surrogate Markers for Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Metabolic-Dysfunction-Associated Steatotic Liver Disease.
- Published in:
- Diagnostics (2075-4418), 2024, v. 14, n. 4, p. 393, doi. 10.3390/diagnostics14040393
- By:
- Publication type:
- Article
Metabolic associated steatotic liver disease misses fewer high-risk patients than metabolic associated fatty liver disease.
- Published in:
- Clinical & Experimental Hepatology, 2024, v. 10, n. 4, p. 249, doi. 10.5114/ceh.2024.145429
- By:
- Publication type:
- Article
Impact of nomenclature as metabolic associated steatotic liver disease on steatotic liver disease prevalence and screening: a prospective population survey in Asians.
- Published in:
- Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 8, p. 1636, doi. 10.1111/jgh.16554
- By:
- Publication type:
- Article
Frequency of significant steatosis and compensated advanced chronic liver disease among adults with chronic liver disease.
- Published in:
- Journal of Gastroenterology & Hepatology, 2023, v. 38, n. 10, p. 1818, doi. 10.1111/jgh.16313
- By:
- Publication type:
- Article
Patient‐reported outcomes in patients with non‐alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire‐non‐alcoholic fatty liver disease/non‐alcoholic steatohepatitis.
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 3, p. 629, doi. 10.1111/jgh.15172
- By:
- Publication type:
- Article
Metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease from clinical to pathological characteristics: a multi-center cross-sectional study in real world.
- Published in:
- Postgraduate Medical Journal, 2024, v. 100, n. 1183, p. 319, doi. 10.1093/postmj/qgae007
- By:
- Publication type:
- Article
Impact of Diabetes Mellitus (DM) and Metabolic Syndrome (MS) on Acute Liver Disease (ALD) and Chronic Liver Disease (CLD).
- Published in:
- European Journal of Cardiovascular Medicine, 2023, v. 13, n. 3, p. 965
- By:
- Publication type:
- Article
Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index at Diagnosis Is Associated with All-Cause Mortality during Follow-Up in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
- Published in:
- Medicina (1010660X), 2024, v. 60, n. 3, p. 381, doi. 10.3390/medicina60030381
- By:
- Publication type:
- Article
Polygenic risk score of metabolic dysfunction-associated steatotic liver disease amplifies the health impact on severe liver disease and metabolism-related outcomes.
- Published in:
- Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-024-05478-z
- By:
- Publication type:
- Article
Two-dimensional shear wave elastography (ElastQ) accurately rules out liver fibrosis and rules in advanced chronic liver disease across liver disease etiologies: a prospective multicenter study.
- Published in:
- Ultrasonography, 2023, v. 42, n. 4, p. 544, doi. 10.14366/usg.23069
- By:
- Publication type:
- Article
Persistently Active Helicobacter pylori Infection Is Associated with the Development of Metabolic Dysfunction-Associated Steatotic Liver Disease.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1073, doi. 10.3390/jcm14041073
- By:
- Publication type:
- Article
Unraveling Metabolic Dysfunction-Associated Steatotic Liver Disease Through the Use of Omics Technologies.
- Published in:
- International Journal of Molecular Sciences, 2025, v. 26, n. 4, p. 1589, doi. 10.3390/ijms26041589
- By:
- Publication type:
- Article
Exogenous Secretin Improves Parenteral Nutrition-associated Liver Disease in Rats.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Research Progress on Non-alcoholic Fatty Liver Disease Induced by Environmental Pollutant.
- Published in:
- Asian Journals of Ecotoxicology, 2024, v. 19, n. 3, p. 158, doi. 10.7524/AJE.1673-5897.20231212001
- By:
- Publication type:
- Article
基于“肝心同病”探析代谢相关脂肪性肝病合并动脉粥样硬化的 病机与治疗思路.
- Published in:
- Journal of Beijing University of Traditional Chinese Medicine, 2023, v. 46, n. 5, p. 697, doi. 10.3969/j.issn.1006-2157.2023.05.016
- By:
- Publication type:
- Article
Reliability and validity of the Chinese version of chronic liver disease questionnaire-nonalcoholic fatty liver disease in patients with nonalcoholic fatty liver disease: a multicenter cross-sectional survey in China.
- Published in:
- Quality of Life Research, 2023, v. 32, n. 3, p. 915, doi. 10.1007/s11136-022-03305-w
- By:
- Publication type:
- Article
Creating a framework for an integrated novel ultrasound clinic for metabolic dysfunction-associated steatotic liver disease.
- Published in:
- British Journal of Healthcare Management, 2024, v. 30, n. 6, p. 1, doi. 10.12968/bjhc.2023.0037
- By:
- Publication type:
- Article
Efficacy and safety of Resmetirom, a selective thyroid hormone receptor-β agonist, in the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-70242-8
- By:
- Publication type:
- Article
Investigating causal associations among gut microbiota, metabolites, and liver diseases: a Mendelian randomization study.
- Published in:
- Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1159148
- By:
- Publication type:
- Article
miRNA‐221: A Potential Biomarker of Progressive Liver Injury in Chronic Liver Disease (CLD) due to Hepatitis B Virus (HBV) and Nonalcoholic Fatty Liver Disease (NAFLD).
- Published in:
- International Journal of Hepatology, 2024, v. 2024, p. 1, doi. 10.1155/2024/4221368
- By:
- Publication type:
- Article
Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review.
- Published in:
- Annals of Medicine, 2022, v. 54, n. 1, p. 1548, doi. 10.1080/07853890.2022.2069854
- By:
- Publication type:
- Article
The important role of immunization in alcoholic and non‐alcoholic chronic liver disease: A population‐based study.
- Published in:
- Journal of Digestive Diseases, 2020, v. 21, n. 10, p. 583, doi. 10.1111/1751-2980.12926
- By:
- Publication type:
- Article
Cholestatic liver disease: Practice guidelines from the Saudi Association for the Study of Liver diseases and Transplantation.
- Published in:
- Saudi Journal of Gastroenterology, 2021, v. 27, p. 1, doi. 10.4103/sjg.sjg_112_21
- By:
- Publication type:
- Article
Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention.
- Published in:
- Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01697-0
- By:
- Publication type:
- Article
Anxiety and depression in metabolic-associated steatotic liver disease: relation with socio-demographic features and liver disease severity.
- Published in:
- Acta Diabetologica, 2024, v. 61, n. 8, p. 1041, doi. 10.1007/s00592-024-02287-0
- By:
- Publication type:
- Article
Increased Renal Expression of Complement Components in Patients With Liver Diseases: Nonalcoholic Steatohepatitis, Alcohol-Associated, Viral Hepatitis, and Alcohol-Viral Combination.
- Published in:
- Toxicological Sciences, 2022, v. 189, n. 1, p. 62, doi. 10.1093/toxsci/kfac070
- By:
- Publication type:
- Article
The Multicomponent Medicinal Product Hepar Compositum Reduces Hepatic Inflammation and Fibrosis in a Streptozotocin- and High-Fat Diet-Induced Model of Metabolic Dysfunction-Associated Steatotic Liver Disease/Metabolic Dysfunction-Associated Steatohepatitis
- Published in:
- Biomedicines, 2023, v. 11, n. 12, p. 3216, doi. 10.3390/biomedicines11123216
- By:
- Publication type:
- Article
Pathology and Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatic Tumors.
- Published in:
- Biomedicines, 2023, v. 11, n. 10, p. 2761, doi. 10.3390/biomedicines11102761
- By:
- Publication type:
- Article
The Potential Role of C-Reactive Protein in Metabolic-Dysfunction-Associated Fatty Liver Disease and Aging.
- Published in:
- Biomedicines, 2023, v. 11, n. 10, p. 2711, doi. 10.3390/biomedicines11102711
- By:
- Publication type:
- Article
Steatotic Liver Disease: Metabolic Dysfunction, Alcohol, or Both?
- Published in:
- Biomedicines, 2023, v. 11, n. 8, p. 2108, doi. 10.3390/biomedicines11082108
- By:
- Publication type:
- Article
Alcohol-Related Liver Disease: An Overview on Pathophysiology, Diagnosis and Therapeutic Perspectives.
- Published in:
- Biomedicines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/biomedicines10102530
- By:
- Publication type:
- Article
The Emerging Role of Branched-Chain Amino Acids in Liver Diseases.
- Published in:
- Biomedicines, 2022, v. 10, n. 6, p. 1444, doi. 10.3390/biomedicines10061444
- By:
- Publication type:
- Article
Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies.
- Published in:
- Biomedicines, 2022, v. 10, n. 1, p. 182, doi. 10.3390/biomedicines10010182
- By:
- Publication type:
- Article
Epigenetics in inflammatory liver diseases: A clinical perspective (Review).
- Published in:
- Experimental & Therapeutic Medicine, 2022, v. 23, n. 5, p. N.PAG, doi. 10.3892/etm.2022.11293
- By:
- Publication type:
- Article
Liver Fibrosis Scores and Coronary Artery Disease: Novel Findings in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2023, v. 16, p. 2627, doi. 10.2147/DMSO.S426102
- By:
- Publication type:
- Article
Fighting liver disease: understanding the integral role of public health.
- Published in:
- Gastrointestinal Nursing, 2014, v. 12, p. S9, doi. 10.12968/gasn.2014.12.Sup10.S9
- By:
- Publication type:
- Article
Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index for Classification of Patients with Steatotic Liver Disease.
- Published in:
- Journal of Obesity & Metabolic Syndrome, 2024, v. 33, n. 3, p. 222, doi. 10.7570/jomes23063
- By:
- Publication type:
- Article
Liver diseases in the general population – the importance of active screening.
- Published in:
- Family Medicine & Primary Care Review, 2023, v. 25, n. 3, p. 270, doi. 10.5114/fmpcr.2023.131299
- By:
- Publication type:
- Article
The Calculation and Evaluation of an Ultrasound-Estimated Fat Fraction in Non-Alcoholic Fatty Liver Disease and Metabolic-Associated Fatty Liver Disease.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 21, p. 3353, doi. 10.3390/diagnostics13213353
- By:
- Publication type:
- Article
Metabolic Dysfunction-Associated Steatotic Liver Disease and Alcohol-Associated Liver Disease: Liver DNA Methylation Analysis—A Systematic Review.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 22, p. 1893, doi. 10.3390/cells13221893
- By:
- Publication type:
- Article
Circular RNA as an Epigenetic Regulator in Chronic Liver Diseases.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 8, p. 1945, doi. 10.3390/cells10081945
- By:
- Publication type:
- Article
The roles and potential mechanisms of plant polysaccharides in liver diseases: a review.
- Published in:
- Frontiers in Pharmacology, 2024, p. 01, doi. 10.3389/fphar.2024.1400958
- By:
- Publication type:
- Article
The effect of liver disease on hepatic microenvironment and implications for immune therapy.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1225821
- By:
- Publication type:
- Article
Copper homeostasis and cuproptosis‐related genes: Therapeutic perspectives in non‐alcoholic fatty liver disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 4830, doi. 10.1111/dom.15846
- By:
- Publication type:
- Article
Profile of spontaneous bacterial peritonitis in non-alcoholic fatty liver disease cirrhosis.
- Published in:
- Asian Journal of Medical Sciences, 2024, v. 15, n. 9, p. 132, doi. 10.3126/ajms.v15i9.66169
- By:
- Publication type:
- Article